Andrew J. Cutler
4 presentations
-
W71. ANTIPSYCHOTIC SWITCHING AMONG PATIENTS WITH BIPOLAR I DEPRESSION AFTER INITIATING CARIPRAZINE VS LUMATEPERONE: A REAL-WORLD CLAIMS-BASED STUDY
-
W82. REAL-WORLD PERSISTENCE ON OLANZAPINE/SAMIDORPHAN VERSUS OTHER ORAL SECOND-GENERATION ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA
-
W93. REAL-WORLD IMPACT OF OLANZAPINE AND SAMIDORPHAN ON RATES OF RELAPSE AMONG YOUNG ADULTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
-
T10. THE PHARMACOKINETIC PROPERTIES AND TARGET ENGAGEMENT EFFECTS OF THE NOVEL SEROTONIN TRANSPORTER MODULATOR, SNTX-2643, IN HEALTHY ADULTS